The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Meyerlustenberger Lachenal Ltd (MLL)

Work +41 44 396 91 91
Fax +41 44 396 91 92

Dr Simon Holzer

Work +41 44 396 92 57
Meyerlustenberger Lachenal Ltd

Work Department

Patents and Life Sciences | Trademarks, Design & Advertising | Arbitration and Litigation


Simon Holzer heads the firm’s Patent and Life Sciences team. He has extensive experience in all areas of IP law, with a focus on patents, trademarks and geographical indications. He has substantial experience in a wide range of industries and technologies, including pharmaceuticals, medical devices, telecommunications, software and foodstuffs. Simon Holzer is also a trusted advisor in pharmaceutical regulatory law. He represents and advises clients in litigation, IP-related arbitration as well as contractual matters concerning in particular technology transfer, licensing and distribution. In 2010 the Swiss parliament appointed Simon Holzer as part-time judge of the Federal Patent Court.


Partner with Meyerlustenberger Lachenal and head of Patent and Life Science Practice Group (since 2012), Foreign Associate with Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP, Chicago (2008–2009), Associate with meyerlustenberger (2005–2011), Admitted to the bar in Switzerland (2005), Freelance associate with a Swiss law firm in Berne (2000–2004), Law Clerk in the judiciary of the Canton of Berne (2000–2001)


German, English, French


European Patent Lawyers Association (EPLAW), Licensing Executives Society (LES), International Association for the Protection of Intellectual Property (AIPPI), Swiss Institute for IP rights (INGRES), Zurich Bar Association (ZAV), IP practice group of Zurich Bar Association, IP practice group of Bernese Bar Association


University of Berne, Dr. iur. (2004), Research scholarship from the Max Planck Institute for Intellectual Property, Competition and Tax Law (2002–2003), University of Berne, lic. iur. (1998)


Healthcare and life sciences

Within: Healthcare and life sciences

Meyerlustenberger Lachenal Ltd (MLL) provides a 'user-friendly' service, covering the drafting of agreements for pharmaceutical companies and research organisations, as well as dispute resolution, pricing negotiation, product liability issues, transactions and regulatory matters under the Therapeutic Product Act. Together with Michael Ritscher, the 'responsive, knowledgeable and easy-to-work-with' Simon Holzer is representing Gilead Sciences in multiple Swiss patent disputes related to Tenofovir and supplementary protection certificates.

[back to top]

Intellectual property

Within: Leading individuals

Simon Holzer - Meyerlustenberger Lachenal Ltd (MLL)

Within: Intellectual property

The 'strong and highly experienced patent litigation group' at Meyerlustenberger Lachenal Ltd (MLL) has 'a good knowledge of the pharmaceutical sector and regulatory requirements' and is perceived as 'approachable, efficient and business-oriented'. The team is best known for its expertise in patent litigation, trade mark and design infringement matters, cases involving EU law, as well as copyright, advertising and brand name aspects. 'Easy-to-work-with and technically strong' Simon Holzer collaborated with 'extremely knowledgeable litigator' Michael Ritscher on the successful representation of Gilead Sciences in all patent disputes related to its Tenofovir patents and supplementary protection certificates. Hilti and AstraZeneca are other clients, which Ritscher acts for in patent disputes. 'Very good lawyers' Guillaume Fournier and Peter Schramm are also noted.

[back to top]

Leading firms: German-speaking Switzerland

Within: Leading firms: German-speaking Switzerland

Providing full-service advice, Meyerlustenberger Lachenal Ltd (MLL) is best known for its intellectual property, private client, real estate, TMT, competition and corporate work. Key names include Simon Holzer, Michael Ritscher , Patricia Guerra, Lukas Bühlmann, Michael Reinle and Mario Strebel.

[back to top]

Back to index

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to